When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CASI - CASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarket
CASI Pharmaceuticals Inc.
CASI Pharmaceuticals (NASDAQ:CASI) has signed a license agreement for exclusive worldwide rights to an anti-CD19 T-cell therapy product (CNCT19) from Juventas Cell Therapy Ltd., a China-based domestic company.
More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,